drugset
drugset / Trial / NCT03974776

Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants

NCT03974776 ↗

Phase 1 Completed 8 enrolled Pfizer
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of PF-06946860 in healthy adult Japanese participants following single dose administration.

Timeline

Start
2019-07-08
Primary completion
2020-01-10
Completion
2020-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ponsegromab Monoclonal antibody — Subcutaneous

Indications

No indication recorded.